Multiple Sclerosis Therapeutics Market Growth Accelerates with Biologics & Precision Medicine| DataM Intelligence
Driven by new biologics and personalized Multiple Sclerosis treatments, the global therapeutics market is forecast to reach USD 46.22B by 2033. AUSTIN, TX, UNITED STATES, December 2, 2025 /EINPresswire.com/ -- According to DataM Intelligence, …